GO:1902870 negative regulation of amacrine cell differentiation: Retinal Interneuron Specification, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:1902870 describes any process that stops, prevents, or reduces the frequency, rate, or extent of amacrine cell differentiation, a key step in retinal interneuron development.
• Amacrine cells are inhibitory retinal interneurons; their correct number and subtype balance are essential for visual processing and sensitivity.
• Key negative regulators include Prdm13, which suppresses specific amacrine subtypes to modulate visual sensitivity, and Barhl2, which influences glycinergic amacrine cell specification.
• Signaling pathways such as Sonic hedgehog (Shh), p53, PTEN/Akt/Tgfβ/Erk, and Foxn4/Lhx2/Ldb1/Rnf12 control the timing and extent of amacrine cell production.
• Dysregulation of amacrine cell differentiation is linked to retinal degenerative diseases and visual dysfunction, making these pathways potential therapeutic targets.
• CRISPR-based knockout, knock-in, and overexpression models in zebrafish, mouse, and human retinal organoids enable precise functional dissection of negative regulators.
Description
The development of the vertebrate retina depends on a precise balance between neural progenitor proliferation and differentiation into distinct cell types. Amacrine cells are inhibitory interneurons that modulate visual signals in the inner retina, and their proper specification is critical for visual sensitivity and circuit function. The Gene Ontology term GO:1902870, negative regulation of amacrine cell differentiation, captures the biological processes that restrain or reduce the generation of amacrine cells from retinal progenitors. Understanding this term is essential for researchers studying retinal development, because failures in negative regulation can lead to altered amacrine cell numbers, disrupted inhibitory circuits, and visual deficits. Mechanistically, negative regulation of amacrine cell differentiation is orchestrated by transcription factors, signaling pathways, and epigenetic regulators that act at specific developmental windows. For example, Prdm13 acts as a transcriptional repressor to limit specific amacrine subtypes and modulate visual sensitivity, while Barhl2 influences the specification of glycinergic amacrine cells. Signaling through Sonic hedgehog, p53, PTEN/Akt/Tgfβ/Erk, and Foxn4/Lhx2/Ldb1/Rnf12 further modulates the timing and extent of amacrine cell production. These findings highlight that negative regulation is not a single event but a network of checkpoints that ensure appropriate cell numbers and subtype diversity. For biomedical researchers, GO:1902870 provides a framework to interrogate how genetic and pharmacological perturbations affect retinal interneuron development. CRISPR-based models, including knockout, point-mutation, knock-in, and overexpression, allow precise testing of candidate regulators in zebrafish, mouse, and human retinal organoids. Such studies are crucial for understanding retinal degenerative diseases and for developing strategies to preserve or restore visual function.
negative regulation of amacrine cell differentiation At A Glance
| GO ID | GO:1902870 |
|---|---|
| GO term | negative regulation of amacrine cell differentiation |
| Ontology | biological_process |
| Synonym | down regulation of amacrine cell differentiation; down-regulation of amacrine cell differentiation; downregulation of amacrine cell differentiation; down regulation of amacrine neuron differentiation; down-regulation of amacrine neuron differentiation; downregulation of amacrine neuron differentiation; inhibition of amacrine cell differentiation; inhibition of amacrine neuron differentiation; negative regulation of amacrine neuron differentiation |
| Major function | Restricts the generation of amacrine cells from retinal progenitors, thereby controlling inhibitory interneuron number and subtype balance |
| Key regulators | Prdm13, Barhl2, PTEN, Foxn4, Lhx2, Ldb1, Rnf12, p53, Sonic hedgehog |
| Associated processes | Retinal neurogenesis, cell-cycle exit, subtype specification, synaptogenesis |
| Research models | Zebrafish, mouse retina, human retinal organoids, heterochronic pellet assays |
What Is GO:1902870?
GO:1902870, negative regulation of amacrine cell differentiation, is defined as any process that stops, prevents, or reduces the frequency, rate, or extent of amacrine cell differentiation. In other words, it encompasses molecular and cellular mechanisms that actively suppress the generation of amacrine cells from retinal progenitor cells, thereby controlling the number and subtype composition of these inhibitory interneurons.
Why Is negative regulation of amacrine cell differentiation Important in Cell Biology?
Negative regulation of amacrine cell differentiation is critical for establishing the correct ratio of excitatory and inhibitory neurons in the retina. Amacrine cells are essential for visual processing, and their dysregulation has been linked to visual sensitivity changes and retinal degenerative conditions. Understanding the negative regulators of this process provides insights into retinal development, disease mechanisms, and potential therapeutic targets for vision restoration.
• Controls the number of inhibitory interneurons in the retina, which is essential for balanced visual signaling.
• Regulates subtype specification, including glycinergic and GABAergic amacrine cells, affecting visual sensitivity.
• Influences retinal synaptogenesis and circuit formation.
• Dysregulation is associated with retinal degenerative diseases and visual dysfunction.
• Provides a model for studying temporal identity and competence in neural development.
• Involves key signaling pathways (Shh, p53, PTEN/Akt/Tgfβ/Erk) that are broadly relevant to cancer and neurodevelopment.
• Offers targets for CRISPR-based gene editing to study and potentially treat retinal disorders.
• Helps explain how progenitor cells choose between proliferation and differentiation.
• Relevant to regenerative medicine approaches aiming to generate specific retinal cell types from stem cells.
• Contributes to understanding of heterochronic mechanisms in retinal development.
What Happens During negative regulation of amacrine cell differentiation?
Transcriptional repression of amacrine subtype programs
In simple terms: Certain proteins act as brakes on the genes that make amacrine cells, preventing too many of a specific subtype from forming.
Prdm13 is a transcriptional repressor that negatively regulates the differentiation of specific amacrine subtypes. In its absence, excessive amacrine cells of certain subtypes are produced, leading to altered visual sensitivity. This demonstrates that transcriptional repression is a key mechanism for fine-tuning amacrine cell numbers and subtypes.
Homeodomain transcription factor control of glycinergic amacrine cells
In simple terms: Barhl2 is a gene that helps decide how many glycinergic amacrine cells are made, acting as a negative regulator.
Barhl2, a homeobox gene, plays a role in the specification of glycinergic amacrine cells. Its function restricts the number of these cells, and loss of Barhl2 leads to an increase in glycinergic amacrine cells, indicating that it negatively regulates their differentiation.
Signaling pathways that limit amacrine cell production
In simple terms: Signals like Sonic hedgehog and p53 can stop progenitor cells from becoming amacrine cells, especially under stress or when development needs to be slowed.
In the absence of Sonic hedgehog, p53 induces apoptosis and inhibits retinal cell proliferation, cell-cycle exit, and differentiation, including amacrine cells. This shows that p53 can negatively regulate amacrine cell differentiation under certain conditions. Additionally, PTEN regulates amacrine cell number by modulating Akt, Tgfβ, and Erk signaling, acting as a negative regulator of amacrine cell production.
Temporal identity factors and competence
In simple terms: Foxn4 and other factors change what cell types progenitors can become over time, and they can also put the brakes on amacrine cell differentiation.
Foxn4 is a temporal identity factor that confers mid/late-early retinal competence and is involved in retinal synaptogenesis. It influences the balance between different cell fates, including amacrine cells, and can negatively regulate their differentiation at specific developmental windows. Similarly, Ldb1- and Rnf12-dependent regulation of Lhx2 controls the relative balance between neurogenesis and gliogenesis, indirectly affecting amacrine cell numbers.
Cell-cell communication and heterochronic regulation
In simple terms: Cells talk to each other to decide when to stop making amacrine cells, and this timing can be studied in special assays.
Heterochronic pellet assays have been used to test cell-cell communication in the mouse retina, revealing that negative regulation of amacrine cell differentiation can be influenced by temporal signals from neighboring cells. This suggests that the process is not cell-autonomous but involves community-level decisions.
Key Genes Involved in GO:1902870 negative regulation of amacrine cell differentiation
The following genes and proteins have been experimentally implicated in the negative regulation of amacrine cell differentiation, based on published studies in zebrafish, mouse, and other vertebrate models.
| Gene | Major Role | Research Relevance |
|---|---|---|
| Prdm13 | Transcriptional repressor that limits specific amacrine subtypes | Modulates visual sensitivity; knockout leads to excess amacrine cells |
| Barhl2 | Homeobox gene regulating glycinergic amacrine cell specification | Loss increases glycinergic amacrine cells; important for subtype balance |
| Pten | Modulates Akt, Tgfβ, and Erk signaling to control amacrine cell number | Negative regulator of amacrine cell production; links to cancer pathways |
| Foxn4 | Temporal identity factor conferring mid/late-early retinal competence | Involved in synaptogenesis and amacrine cell differentiation timing |
| Lhx2 | Transcription factor regulated by Ldb1 and Rnf12 | Controls balance between neurogenesis and gliogenesis |
| Ldb1 | Co-factor regulating Lhx2 | Affects neurogenesis/gliogenesis balance |
| Rnf12 | E3 ubiquitin ligase regulating Lhx2 | Modulates Lhx2 levels and retinal cell fate |
| p53 | Tumor suppressor inducing apoptosis and inhibiting differentiation | Inhibits retinal cell proliferation and differentiation in absence of Shh |
| Sonic hedgehog (Shh) | Signaling molecule that promotes proliferation | Its absence leads to p53-mediated inhibition of differentiation |
| Akt | Kinase in PTEN pathway | Modulates amacrine cell number |
| Tgfβ | Signaling pathway | Modulates amacrine cell number |
| Erk | MAP kinase pathway | Modulates amacrine cell number |
| GABAergic markers | Subtype-specific markers | Used to identify amacrine subtypes |
| Glycinergic markers | Subtype-specific markers | Used to identify glycinergic amacrine cells |
| Islet1 | Transcription factor in amacrine cells | Marker for amacrine cells |
| Pax6 | Progenitor transcription factor | Upstream regulator of retinal development |
| NeuroD | Differentiation factor | Involved in amacrine cell differentiation |
How Is negative regulation of amacrine cell differentiation Regulated?
The negative regulation of amacrine cell differentiation is controlled by a combination of transcriptional repressors (e.g., Prdm13, Barhl2), signaling pathways (e.g., Shh, p53, PTEN/Akt/Tgfβ/Erk), and temporal identity factors (e.g., Foxn4). These regulators act at different developmental stages to ensure appropriate amacrine cell numbers and subtypes. Cell-cell communication and heterochronic mechanisms further modulate the timing of differentiation.
negative regulation of amacrine cell differentiation and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| Prdm13 | Visual sensitivity changes | Prdm13 knockout mouse, zebrafish |
| Pten | Retinal degeneration, cancer | Pten conditional knockout mouse |
| Barhl2 | Glycinergic amacrine cell imbalance | Barhl2 knockout mouse |
| p53 | Apoptosis, retinal degeneration | p53 mutant zebrafish |
| Foxn4 | Synaptogenesis defects | Foxn4 knockout mouse |
Retinal degenerative diseases
Dysregulation of amacrine cell differentiation has been linked to retinal degenerative conditions. For example, Prdm13-mediated negative regulation affects visual sensitivity, and its perturbation may contribute to visual dysfunction. PTEN signaling, which controls amacrine cell number, is also implicated in retinal degeneration and cancer.
Visual sensitivity disorders
Altered amacrine cell numbers or subtypes can lead to changes in visual sensitivity. Prdm13 knockout mice exhibit altered visual sensitivity, suggesting that negative regulation of amacrine cell differentiation is critical for normal visual function.
Cancer and cell cycle dysregulation
Pathways such as p53 and PTEN, which negatively regulate amacrine cell differentiation, are well-known tumor suppressors. Their roles in retinal development provide insights into how cell cycle exit and differentiation are coupled, with implications for cancer biology.
From negative regulation of amacrine cell differentiation-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of Prdm13 increase amacrine cell number? | Prdm13 knockout mouse or zebrafish |
| How does PTEN signaling affect amacrine cell number? | Pten conditional knockout mouse |
| What is the role of Barhl2 in glycinergic amacrine cells? | Barhl2 knockout mouse |
| How does p53 inhibit differentiation in absence of Shh? | p53 mutant zebrafish |
| Does Foxn4 regulate temporal competence? | Foxn4 overexpression or knockout in mouse retina |
| How do Ldb1 and Rnf12 regulate Lhx2? | Ldb1/Rnf12 knockout or knock-in mouse |
How to Study the negative regulation of amacrine cell differentiation Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Immunohistochemistry | Amacrine cell number and subtype markers | Quantify changes after gene knockout |
| Single-cell RNA-seq | Gene expression profiles of retinal cells | Identify differentiation trajectories |
| Heterochronic pellet assay | Cell-cell communication effects on differentiation | Test temporal signals |
| CRISPR knockout | Loss-of-function effects | Determine if gene is necessary for negative regulation |
| CRISPR knock-in | Tagged protein localization or reporter expression | Track protein dynamics |
| Overexpression | Gain-of-function effects | Test if gene is sufficient to inhibit differentiation |
| Western blot | Protein levels and signaling activity | Assess PTEN/Akt/Erk pathways |
| Electroretinography (ERG) | Visual function | Measure visual sensitivity changes |
Immunohistochemistry and imaging
Immunostaining for amacrine cell markers (e.g., Islet1, GABA, glycine) combined with confocal imaging allows quantification of amacrine cell numbers and subtypes in retinal sections. This method is widely used to assess changes in differentiation after genetic manipulation.
Transcriptomics and single-cell RNA-seq
RNA sequencing of retinal tissue or single cells can reveal changes in gene expression programs associated with amacrine cell differentiation. This helps identify downstream targets of negative regulators like Prdm13 and Barhl2.
Heterochronic pellet assay
This assay tests cell-cell communication by co-culturing retinal cells from different developmental stages. It has been used to study temporal signals that negatively regulate amacrine cell differentiation.
CRISPR-based gene editing
CRISPR knockout, knock-in, and overexpression models in zebrafish, mouse, and human retinal organoids enable precise functional testing of candidate negative regulators. These approaches can reveal causal roles in amacrine cell differentiation.
How CRISPR Can Be Used to Study GO:1902870 negative regulation of amacrine cell differentiation
Knockout
CRISPR knockout of candidate negative regulators such as Prdm13, Barhl2, or Pten in zebrafish or mouse models can reveal whether they are necessary to limit amacrine cell differentiation. For example, Prdm13 knockout leads to increased amacrine cells and altered visual sensitivity.
Point Mutation
Introducing specific point mutations in genes like Barhl2 or Foxn4 can dissect domain-specific functions. This is useful for separating DNA-binding from protein-protein interaction domains in transcriptional repressors.
Knock-in
Knock-in of fluorescent reporters (e.g., GFP) into endogenous loci such as Prdm13 or Foxn4 allows real-time visualization of their expression during retinal development. This helps map the timing of negative regulation.
Overexpression
Overexpression of negative regulators like Prdm13 or Foxn4 in retinal progenitors can test whether they are sufficient to inhibit amacrine cell differentiation. This approach can also be used in human retinal organoids to model disease.
How EDITGENE Supports negative regulation of amacrine cell differentiation Research
Researchers studying negative regulation of amacrine cell differentiation-related genes often need to determine whether a candidate gene is causally involved in restricting amacrine cell numbers or subtypes. This requires precise genetic models that can knockout, mutate, tag, or overexpress the gene of interest in relevant retinal cell types.
Contact EDITGENE today to design your custom CRISPR model for negative regulation of amacrine cell differentiation research.
Frequently Asked Questions About negative regulation of amacrine cell differentiation
What is GO:1902870?
GO:1902870 is the Gene Ontology term for negative regulation of amacrine cell differentiation, describing any process that stops, prevents, or reduces the differentiation of amacrine cells in the retina.
What genes are involved in negative regulation of amacrine cell differentiation?
Key genes include Prdm13, Barhl2, Pten, Foxn4, Lhx2, Ldb1, Rnf12, p53, and Sonic hedgehog.
How does Prdm13 regulate amacrine cell differentiation?
Prdm13 acts as a transcriptional repressor that limits specific amacrine subtypes, and its loss leads to increased amacrine cells and altered visual sensitivity.
What is the role of Barhl2 in amacrine cells?
Barhl2 is a homeobox gene that negatively regulates glycinergic amacrine cell specification; its loss increases glycinergic amacrine cells.
How does PTEN affect amacrine cell number?
PTEN modulates Akt, Tgfβ, and Erk signaling to negatively regulate amacrine cell production.
What signaling pathways control amacrine cell differentiation?
Sonic hedgehog, p53, PTEN/Akt/Tgfβ/Erk, and Foxn4 pathways are involved in negative regulation.
What diseases are linked to amacrine cell differentiation?
Dysregulation is associated with retinal degenerative diseases and visual sensitivity disorders.
How can I study negative regulation of amacrine cell differentiation?
Use CRISPR knockout, knock-in, overexpression in zebrafish, mouse, or human retinal organoids, combined with immunohistochemistry and RNA-seq.
What is the heterochronic pellet assay?
It is a method to test cell-cell communication in the mouse retina, used to study temporal signals that regulate amacrine cell differentiation.
What models are available for amacrine cell research?
Zebrafish, mouse retina, and human retinal organoids are commonly used, along with heterochronic pellet assays.
Conclusion
Negative regulation of amacrine cell differentiation (GO:1902870) is a critical process that ensures the correct number and subtype balance of inhibitory interneurons in the retina. Key regulators such as Prdm13, Barhl2, PTEN, and Foxn4 have been identified through studies in zebrafish and mouse models. Understanding these mechanisms provides insights into retinal development, visual function, and disease, and offers opportunities for therapeutic intervention. CRISPR-based models and advanced imaging and sequencing methods are essential tools for dissecting this process and translating findings into clinical applications.
References
- 1. Prykhozhij SV. 2010. In the absence of Sonic hedgehog, p53 induces apoptosis and inhibits retinal cell proliferation, cell-cycle exit and differentiation in zebrafish.. PLoS One 5(10):e13549 PMID: 21042410
- 2. Watanabe S et al.. 2015. Prdm13 regulates subtype specification of retinal amacrine interneurons and modulates visual sensitivity.. J Neurosci 35(20):8004-20 PMID: 25995483
- 3. Mo Z et al.. 2004. Role of the Barhl2 homeobox gene in the specification of glycinergic amacrine cells.. Development 131(7):1607-18 PMID: 14998930
- 4. Tachibana N et al.. 2016. Pten Regulates Retinal Amacrine Cell Number by Modulating Akt, Tgfβ, and Erk Signaling.. J Neurosci 36(36):9454-71 PMID: 27605619
- 5. Jusuf PR et al.. 2011. Origin and determination of inhibitory cell lineages in the vertebrate retina.. J Neurosci 31(7):2549-62 PMID: 21325522
- 6. Tachibana N et al.. 2017. Heterochronic Pellet Assay to Test Cell-cell Communication in the Mouse Retina.. Bio Protoc 7(3) PMID: 28367479
- 7. Liu S et al.. 2020. Foxn4 is a temporal identity factor conferring mid/late-early retinal competence and involved in retinal synaptogenesis.. Proc Natl Acad Sci U S A 117(9):5016-5027 PMID: 32071204
- 8. de Melo J et al.. 2018. Ldb1- and Rnf12-dependent regulation of Lhx2 controls the relative balance between neurogenesis and gliogenesis in the retina.. Development 145(9) PMID: 29650591
